Concepedia

Michael K. Pugsley

MK

Statistics

Publications

42

Citations

1.7K

H-Index

23

Active since

1992

Affiliations

University of British Columbia(Current)

Eli Lilly (United States)

Amgen (United States)

United States Food and Drug Administration

St Thomas' Hospital

Michael K. Pugsley is an author at University of British Columbia specializing in pharmacology, medicine, and physiology.

ORCID

Top concepts

Publications per year

1992–2023

42

Publications

42

An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells.

Elisa Vega‐Avila, Michael K. Pugsley · PubMed · 2011 · 284 citations

, , +22

Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics

Hugo M. Vargas, Alan Bass, Alexander Breidenbach et al. · Journal of Pharmacological and Toxicological Methods · 2008 · 124 citations

, , +7

Benchmarking Safety Pharmacology regulatory packages and best practice

Silvana Lindgren, Alan Bass, Richard J. Briscoe et al. · Journal of Pharmacological and Toxicological Methods · 2008 · 107 citations

, , +4

Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates

Enda Hayes, Michael K. Pugsley, W.P. Penz et al. · Journal of Pharmacological and Toxicological Methods · 1994 · 91 citations

, , +6

Safety pharmacology investigations on the nervous system: An industry survey

Simon Authier, Joseph C. Arezzo, Marcus S. Delatte et al. · Journal of Pharmacological and Toxicological Methods · 2016 · 84 citations

, , +13

1–5 of 42